Press release
Gouty Arthritis Market Anticipated To Witness Robust Growth, Surpassing $4.9 Billion By 2029
Gouty Arthritis
What Is the Current Gouty Arthritis Market Size and Its Estimated Growth Rate?
The gouty arthritis market size has experienced strong growth in recent years. It will rise from $3.44 billion in 2024 to $3.7 billion in 2025, at a compound annual growth rate (CAGR) of 7.6%. This growth is driven by the high prevalence of chronic diseases, greater alcohol consumption, a growing elderly population, increasing acceptance of advanced regeneration therapies, and rising healTH*Care expenditures.
The gouty arthritis market is anticipated to grow strongly, reaching $4.9 billion by 2029 at a CAGR of 7.2%. The forecast growth is driven by improved healTH*Care infrastructure, rising obesity rates, a higher incidence of gout, and increased public awareness. Trends to watch include growing demand for effective treatments, regenerative therapies, technological advancements, product launches, and regulatory approvals.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16070
How Are Emerging Segments Shaping the Gouty Arthritis Market Landscape?
The gouty arthritis market covered in this report is segmented -
1) By Type: Acute Gouty Arthritis, Chronic Gouty Arthritis
2) By Treatment: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Pain Reliever, Corticosteroids, Xanthine Oxidase Inhibitors, Uricosurics, Others Treatments
3) By Diagnosis: Joint Fluid Test, Blood Test, X-Ray Imaging, Ultrasound, Dual Energy Computed Tomography (CT) Scan, Other Diagnosis
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Others Distribution Channels
5) By End-Users: Hospitals, Specialty Clinics, Other End-Users
Subsegments:
1) By Acute Gouty Arthritis: Monosodium Urate Crystals-Induced Acute Gout, Acute Gout Attack (Intermittent Flares), Severe Acute Gout With Joint Deformities
2) By Chronic Gouty Arthritis: Tophaceous Gout (Presence Of Uric Acid Deposits), Chronic Gout With Joint Damage, Chronic Gout With Renal Complications, Chronic Gout With Comorbidities (Hypertension, Diabetes)
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16070&type=smp
Which Growth Factors Are Influencing Gouty Arthritis Market Expansion?
The rising rate of obesity is fueling the gouty arthritis market. Obesity leads to higher uric acid levels and joint stress, major contributors to gout. The World Health Organization reported in March 2022 that 1 billion people-650 million adults, 340 million teens, and 39 million children-were obese. That number is expected to grow, with 167 million projected to suffer obesity-related health issues by 2025. This trend supports the expansion of the gouty arthritis market.
Who Are the Dominant Players Across Different Gouty Arthritis Market Segments?
Major companies operating in the gouty arthritis market are Pfizer Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Bristol Myers Squibb, AstraZeneca plc, Novartis International AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, UCB S.A., Boehringer Ingelheim International GmbH, Sun Pharmaceutical Industries Ltd., Horizon Therapeutics plc, Dr. Reddy's Laboratories Ltd., Amneal Pharmaceuticals Inc., Lupin Pharmaceuticals Inc.
What Are the Major Trends Shaping the Gouty Arthritis Market?
Significant businesses in the gouty arthritis industry are amplifying their product innovation endeavors, with the goal of unveiling new products like cortrophin gel. This gel is essentially a repository corticotropin injection and a refined version of the adrenocorticotropic hormone (ACTH). It's primarily used in treating several acute and autoimmune conditions, including gouty arthritis. For illustration, ANI Pharmaceuticals, a pharmaceutical corporation based in the United States, was awarded FDA approval in October 2023 for their new 1-mL vial size Purified Cortrophin Gel. This product is purposed for the supplementary treatment of specific patients suffering from abrupt flare-ups of gouty arthritis. Currently, Cortrophin Gel is the solitary FDA-sanctioned ACTH therapy suitable for treating patients enduring acute gouty arthritis flare-ups.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/gouty-arthritis-global-market-report
Which Geographic Regions Are Expected to Dominate the Gouty Arthritis Market in the Coming Years?
North America was the largest region in the gouty arthritis market in 2023. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the gouty arthritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Gouty Arthritis Market?
2. What is the CAGR expected in the Gouty Arthritis Market?
3. What Are the Key Innovations Transforming the Gouty Arthritis Industry?
4. Which Region Is Leading the Gouty Arthritis Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gouty Arthritis Market Anticipated To Witness Robust Growth, Surpassing $4.9 Billion By 2029 here
News-ID: 4040107 • Views: …
More Releases from The Business Research Company
Trends in Growth, Segment Analysis, and Competitive Strategies Influencing the M …
The meal replacement market is gaining significant momentum as consumer preferences shift toward convenient and health-focused nutrition solutions. With rising awareness about preventive healthcare and personalized diets, this sector is set for considerable expansion. Let's explore how the market size is expected to evolve, who the key players are, emerging trends, and the main segments driving this growth.
Projected Growth Trajectory of the Meal Replacement Market Size
The meal replacement…
Leading Companies Reinforcing Their Presence in the Malted Barley Market
The malted barley industry is positioned for steady expansion as demand grows across various sectors. With increasing interest from craft brewers and functional food producers, this market is set to experience meaningful growth driven by innovation and sustainability efforts. Let's dive into the current market size, key players shaping the industry, trends influencing its trajectory, and detailed segment insights.
Projected Market Size and Growth Outlook of the Malted Barley Market …
Future Perspective: Key Trends Shaping the Low-calorie Food Market up to 2030
The low-calorie food market is poised for significant expansion as consumer preferences shift toward healthier eating habits and more personalized nutrition options. Advances in product innovation and supportive regulatory frameworks are expected to drive rapid growth over the coming years. Here's an overview of the market size, key players, emerging trends, and segmentation shaping this evolving industry.
Projected Expansion of the Low-calorie Food Market Size Through 2030
The low-calorie food…
Competitive Landscape: Leading Companies and New Entrants in the Liquid Nutritio …
The liquid nutritional supplement sector is on the rise, driven by evolving consumer preferences and innovations in health and wellness. With growing awareness about personalized nutrition and preventive healthcare, this market is set to witness substantial growth over the coming years. Let's explore the market's projected size, major players, emerging trends, and key segments shaping this dynamic industry.
Projected Market Value and Growth Trajectory of the Liquid Nutritional Supplement Market …
More Releases for Gout
Chronic Gout Market Trends, Therapeutics, and Growth Opportunities
Chronic gout is a progressive form of arthritis characterized by elevated uric acid levels, leading to severe joint pain, inflammation, and long-term joint damage. This condition affects millions worldwide, often resulting in impaired mobility and reduced quality of life. With rising prevalence due to lifestyle changes, aging populations, and dietary habits, the Chronic Gout market is witnessing a surge in demand for advanced therapeutics, early diagnostics, and patient management solutions.
Download…
Chronic Gout Market Massive Growth opportunity Ahead
Introduction
Chronic gout is a form of arthritis characterized by recurrent attacks of severe pain, swelling, and inflammation in the joints, often due to the accumulation of uric acid crystals. This condition typically affects the big toe but can also impact other joints, including the knees, elbows, and wrists. Uric acid, a by-product of purine metabolism, accumulates in the body due to overproduction or underexcretion by the kidneys, leading to hyperuricemia…
Gout Market Innovations in Pain Management and Treatment
On April 08, 2025, Exactitude Consultancy., Ltd. announces the release of the report "Global Gout Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2034". The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many…
Gout Therapeutics Market Analysis By Drug Class (Nonsteroidal Anti-inflammatory …
Report Summary
The global gout therapeutics market was valued at USD 2.78 Billion in 2021 and is expected to grow at a CAGR of 13.7% during the forecast period 2023-2032.
Gout Therapeutics Market Introduction
The deposition of monosodium crystals (MSU) into the distal joints and peripheral tissues results in gout, an inflammatory arthritic disease. Gout is a typical type of painful inflammatory arthritis. One joint is typically affected at a time (often…
Global Gout Drugs Market Analysis (2020-2025)
Global Info Research offers a latest published report on Gout Drugs Analysis and Forecast 2020-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Gout Drugs Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
Click to view the full report TOC, figure and tables:
https://www.globalinforesearch.com/reports/371311/gout-drugs
Market…
Gout Therapeutics Market Emerging Trends And Forecast By 2025
Global Gout Therapeutics Market: Snapshot
The objective of treatment during a severe gout attack involves suppressing inflammation and controlling pain. The treatment of inflammation and pain can be attained with non-steroidal anti-inflammatory drugs, colchicine, or corticosteroids. The line of treatment chosen that would be suitable depends on the co-morbid medical conditions of the patient, side effect profile, and other medications.
Patients with multiple episodes of severe gout attacks every year or with…
